scholarly article | Q13442814 |
P2093 | author name string | Anil Chandraker | |
Sudipta Tripathi | |||
Paloma Leticia Martin-Moreno | |||
P2860 | cites work | Altered balance between effector T cells and FOXP3+ HELIOS+ regulatory T cells after thymoglobulin induction in kidney transplant recipients | Q46987447 |
In Vivo Attenuation of Antibody-Mediated Acute Renal Allograft Rejection by Ex Vivo TGF-β-Induced CD4+Foxp3+ Regulatory T Cells | Q47140596 | ||
Guiding regulatory T cells to the allograft | Q47345472 | ||
Navigating T-Cell Immunometabolism in Transplantation | Q49990145 | ||
Tissue-resident Lymphocytes in Solid Organ Transplantation: Innocent Passengers or the key to Organ Transplant Survival? | Q50027515 | ||
The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. | Q50796005 | ||
Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival. | Q51095965 | ||
Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells. | Q53370380 | ||
Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model | Q56898163 | ||
Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation | Q56899012 | ||
In vitro expansion improves in vivo regulation by CD4+CD25+ regulatory T cells | Q56900856 | ||
Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE | Q79906320 | ||
Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo | Q84186549 | ||
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells | Q30300134 | ||
Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept-Treated Kidney Transplant Patients | Q30360800 | ||
Epigenetic control of the foxp3 locus in regulatory T cells | Q33273617 | ||
Once a Treg, always a Treg? | Q33561651 | ||
Immune reconstitution following rabbit antithymocyte globulin. | Q33827314 | ||
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor | Q34046489 | ||
IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells | Q34651540 | ||
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation | Q34922215 | ||
Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly | Q35553381 | ||
Metformin Ameliorates Inflammatory Bowel Disease by Suppression of the STAT3 Signaling Pathway and Regulation of the between Th17/Treg Balance | Q35770489 | ||
Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action | Q36350238 | ||
Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells | Q36420758 | ||
Type 1 diabetes immunotherapy using polyclonal regulatory T cells | Q36509805 | ||
Infectious tolerance and the long-term acceptance of transplanted tissue | Q36563558 | ||
Thymic versus induced regulatory T cells - who regulates the regulators? | Q36959215 | ||
Regulatory T-cell therapy for transplantation: how many cells do we need? | Q38025843 | ||
Treg(s) in Cancer: Friends or Foe? | Q38442706 | ||
Regulatory T cells: tolerance induction in solid organ transplantation | Q38557841 | ||
Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. | Q38662974 | ||
A Novel Model on DST-Induced Transplantation Tolerance by the Transfer of Self-Specific Donor tTregs to a Haplotype-Matched Organ Recipient | Q38922184 | ||
Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation | Q39219498 | ||
Cell Therapy in Kidney Transplantation: Focus on Regulatory T Cells | Q39279238 | ||
Transplant trials with Tregs: perils and promises | Q39406891 | ||
Interleukin-12 (IL-12p70) Promotes Induction of Highly Potent Th1-Like CD4(+)CD25(+) T Regulatory Cells That Inhibit Allograft Rejection in Unmodified Recipients. | Q39665949 | ||
Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques. | Q40451305 | ||
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
Phenotypic Complexity of the Human Regulatory T Cell Compartment Revealed by Mass Cytometry | Q40680881 | ||
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial | Q42232023 | ||
Foxp3+ regulatory T cells participate in repair of ischemic acute kidney injury. | Q45922599 | ||
Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells | Q46025217 | ||
Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells | Q46057972 | ||
CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H. | Q46763767 | ||
P433 | issue | 11 | |
P304 | page(s) | 1760-1764 | |
P577 | publication date | 2018-05-22 | |
P1433 | published in | Clinical Journal of the American Society of Nephrology | Q15757929 |
P1476 | title | Regulatory T Cells and Kidney Transplantation | |
P478 | volume | 13 |
Q91578166 | Analyses of Programmed Cell Death Protein 1 in High Immunologic-Risk Transplant Patients |
Q90694798 | Korean Red Ginseng Plays An Anti-Aging Role by Modulating Expression of Aging-Related Genes and Immune Cell Subsets |
Q90291193 | Stability and inhibitory function of Treg cells under inflammatory conditions in vitro |
Q59791597 | Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation |
Search more.